Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin J Churchyard

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden SettingsKarl T Johnson, Gavin J Churchyard, Hojoon Sohn, et al.
Lancet (London, England)|March 21, 2006
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentElizabeth L Corbett, Barbara Marston, Gavin J Churchyard, et al.
BMJ Open|May 26, 2018
Linkage to care among adults being investigated for tuberculosis in South Africa: pilot study of a case manager interventionNoriah Maraba, Violet Chihota, Kerrigan McCarthy, et al.
AIDS (London, England)|September 12, 2008
Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South AfricaPaul Mee, Katherine L Fielding, Salome Charalambous, et al.
Lancet (London, England)|August 28, 2009
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health responseSalim S Abdool Karim, Gavin J Churchyard, Quarraisha Abdool Karim, et al.
AIDS (London, England)|August 21, 2007
Business and AIDS: sectoral challenges and opportunitiesMark D Weston, Gavin J Churchyard, David Mametja, et al.
American Journal of Industrial Medicine|June 21, 2008
The burden of silicosis, pulmonary tuberculosis and COPD among former Basotho goldminersBrendan V Girdler-Brown, Neil W White, Rodney I Ehrlich, et al.
Plos One|December 17, 2020
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19Lucy Chimoyi, Kavindhran Velen, Gavin J Churchyard, et al.
AIDS (London, England)|November 17, 2010
Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood?Alison D Grant, Katherine L Fielding, Salome Charalambous, et al.
BMJ Global Health|July 9, 2020
Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping reviewLucy Andere Chimoyi, Christian Lienhardt, Nishila Moodley, et al.
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2018
Cost-effectiveness of Preventive Therapy for Tuberculosis With Isoniazid and Rifapentine Versus Isoniazid Alone in High-Burden SettingsKarl T Johnson, Gavin J Churchyard, Hojoon Sohn, et al.
Lancet (London, England)|March 21, 2006
Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatmentElizabeth L Corbett, Barbara Marston, Gavin J Churchyard, et al.
BMJ Open|May 26, 2018
Linkage to care among adults being investigated for tuberculosis in South Africa: pilot study of a case manager interventionNoriah Maraba, Violet Chihota, Kerrigan McCarthy, et al.
AIDS (London, England)|September 12, 2008
Evaluation of the WHO criteria for antiretroviral treatment failure among adults in South AfricaPaul Mee, Katherine L Fielding, Salome Charalambous, et al.
Lancet (London, England)|August 28, 2009
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health responseSalim S Abdool Karim, Gavin J Churchyard, Quarraisha Abdool Karim, et al.
AIDS (London, England)|August 21, 2007
Business and AIDS: sectoral challenges and opportunitiesMark D Weston, Gavin J Churchyard, David Mametja, et al.
American Journal of Industrial Medicine|June 21, 2008
The burden of silicosis, pulmonary tuberculosis and COPD among former Basotho goldminersBrendan V Girdler-Brown, Neil W White, Rodney I Ehrlich, et al.
Plos One|December 17, 2020
An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19Lucy Chimoyi, Kavindhran Velen, Gavin J Churchyard, et al.
AIDS (London, England)|November 17, 2010
Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood?Alison D Grant, Katherine L Fielding, Salome Charalambous, et al.
BMJ Global Health|July 9, 2020
Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping reviewLucy Andere Chimoyi, Christian Lienhardt, Nishila Moodley, et al.
Pageof 14